Inhibition of quorum sensing by compounds from two Eunicea species and synthetic saturated alkylglycerols
DOI:
https://doi.org/10.17533/udea.vitae.v25n2a05Keywords:
Natural products, alkylglycerols, synthesis, quorum sensing inhibition, antibacterialAbstract
Background: the emergence of bacterial resistance has led to a search for new natural products as alternatives starting points to prevent and control diseases caused by microorganisms. Among the potential candidates were bioactive compounds from octocorals of the genus Eunicea due to their chemical structures and their wide range of biological activities. Objective: the purpose of this study was to evaluate the quorum sensing inhibition (QSI) and antibacterial activity of compounds previously isolated from two Eunicea species and synthesized alkylglycerols (AKG). Methods: the QSI of three nonpolar compounds and a mixture of AKGs from Eunicea were evaluated by a microtiter plate assay using Chromobacterium violaceum (ATCC 31532). Four naturally occurring, saturated, and enantiomerically pure AKGs, all of which were derived from the chiral precursor (R)-solketal, were synthesized from alkyl chains of 12, 14, 16 and 18 carbons, and their structures were spectroscopically verified by NMR, ESI-MS and optical rotation data. Their QSI by the disc diffusion assay and minimum inhibitory concentrations (MIC) against 14 clinical bacterial isolates in microtiter plates were determined. Results: cembradiene 1, the AKG mixture and AKG (2S)-3-O-dodecyl-1,2-propanediol 4 inhibit QS at the same concentration as kojic acid (10 µg/well or 20 µg/disc, respectively). In this study, the bioactive compounds 1, stearyl oleate 2, acylglycerol 3 and AKGs 4 and (2S)-3-O-tetradecyl-1,2-propanediol 5 showed in vitro IQS activity for the first time. Additionally, 4 and 5 displayed in vitro antibacterial activity against Listeria innocua and Staphylococcus aureus (MIC = 32 µg/mL for both 4 and 5), Enterococcus faecalis (128 µg/mL and 64 µg/mL respectively), Micrococcus luteus (128 µg/mL for both) and Brevibacillus brevis (Bacillus brevis) (512 µg/mL and 64 µg/mL respectively). Conclusion: results suggest that natural compounds 1, 2, 3, 4 and 5 showed QSI, also 4 and 5 have antibacterial activity and they are an interesting alternative to continue researching their effect against pathogenic microorganisms.
Downloads
References
El Arbi M, Théolier J, Pigeon P, Jellali K, Trigui F, Top S, Aifa S, Fliss I, Jaouen G, Hammami R. Antibacterial properties and mode of action of new triaryl butane citrate compounds. Eur J Med Chem. 2014 April; 76: 408-13.
Benzekri R, Bouslama L, Papetti A, Snoussi M, Benslimene I, Hamami M, Limam F. Isolation and identification of an antibacterial compound from Diplotaxis harra (Forssk.) Boiss. Ind Crops Prod. 2016 February; 80: 228-34.
Habbu P, Warad V, Shastri R, Madagundi S, Kulkarni VH. Antimicrobial metabolites from marine microorganisms. ChinJ Nat Med. 2016 February; 14 (2): 101-16.
Brango-Vanegas J, Costa GM, Ortmann CF, Schenkel EP. Reginatto FH, Ramos FA, Arevalo-Ferro C, Castellanos L.
Glycosylflavonoids from Cecropia pachystachya Trécul are quorum sensing inhibitors. Phytomedicine. 2014 April; 21 (5): 670-75.
Dobretsov S, Teplitski M, Bayer M, Gunasekera S, Proksch P, Paul VJ. Inhibition of marine biofouling by bacterial quorum sensing inhibitors. Biofouling. 2011 September; 27 (8): 893-05.
Maisarah NS, Yin WF, Chan KG. Caffeine as a potential quorum sensing inhibitor. Sensors. 2013 April; 13 (4): 5117-29.
Castillo-Juárez I, Maeda T, Mandujano-Tinoco E, Tomás M, Pérez-Eretza B, García-Contreras S., Wood TK, García Contreras R. Role of quorum sensing in bacterial infections. World J Clin Cases. 2015 July; 3 (7): 575-98.
Rasmussen TB, Givskov M. Quorum-sensing inhibitors as antipathogenic drugs. Int J Med Microbiol. 2006 April; 296 (2-3): 149-61.
Castellanos LH, Mayorga HW, Duque CB. Estudio de la composición química y actividad antifouling del extracto de la esponja marina Cliona delitrix. Vitae. 2010 may-august; 17 (2): 209-24.
Mayorga H, Urrego NF, Castellanos L, Duque, C. Cembradienes from the Caribbean Sea whip Eunicea sp. Tetrahedron Lett. 2011 May; 52: 2515-18.
Tello E, Castellanos L, Duque C, Synthesis of cembranoid analogues and evaluation of their potential as quorum sensing inhibitors. Bioorg Med Chem. 2013 January; 21 (1): 242-56.
Martínez YD, Vanegas GL, Reina LG, Mayorga HW, Arévalo Ferro C, Ramos FR, Duque CB, Castellanos LH. Biofilm
inhibition activity of compounds isolated from two Euniceaspecies collected at the Caribbean Sea. Rev Bras Farmacogn. 2015 November-December; 25 (6): 605-11.
Deniau AL, Mosset P, Pédrono F, Mitre R, Le Bot D, Legrand AB. Multiple beneficial health effects of natural alkylglycerols from shark liver oil. Mar Drugs. 2010 July; 8 (7): 2175-84
Iannitti T, Palmieri B. An Update on the therapeutic role of alkylglycerols. Mar Drugs. 2010 August; 8 (8): 2267-300.
Magnusson CD, Gudmundsdottir AV, Haraldsson GG. Chemoenzymatic synthesis of a focused library of enantiopure structured 1-O-alkyl-2,3-diacyl-sn-glycerol type ether lipids. Tetrahedron. 2011 March; 67 (10): 1821-36.
Pemha R, Pegnyemb DE, Mosset P. Synthesis of (Z)-(20R)-1-O-(20-methoxynonadec-100-enyl)-sn-glycerol, a new analog of bioactive ether lipids. Tetrahedron. 2012 April; 68 (14): 2973-83
Ved HS, Gustow E, Mahadevans V, Pieringer RA. Dodecylglycerol a new type of antibacterial agent which stimulates autolysin activity in Streptococcus faecium ATCC 9790. J Biol Chem. 1984 July; 259 (13): 8115-21.
Lin YC, Schlievert PM, Anderson MJ, Fair CL. Schaefers MM, Muthyala R, Peterson ML. Glycerol monolaurate and
dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. PLoS One 2009 October, 4 (10), e7499
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Vitae
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
